- UBRELVY® is the first and only oral CGRP receptor antagonist (gepant) approved by Health Canada for the acute treatment of migraine
-- UBRELVY® was demonstrated to reduce or eliminate migraine pain with a single oral tablet, with the flexibility to take an optional second dose for persistent pain
Read more at newswire.ca